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Higher arterial pressure during
cardiopulmonary bypass may not reduce
the risk of acute kidney injury
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Henrik C. Arendrup1 and Daniel A. Steinbrüchel1
Abstract
Background: Acute kidney injury after cardiac surgery is common and associated with increased mortality. It is
unknown whether an intended higher arterial pressure during cardiopulmonary bypass reduces the incidence of
acute and chronic kidney injury.
Methods: Patients were randomised either to a control group or a high pressure group (arterial pressure > 60mmHg).
The inclusion criteria were age > 70 years, combined cardiac surgery and serum creatinine < 200 μmol/L. Glomerular
filtration rate using the Cr-EDTA clearance method was measured the day before surgery and 4 months postoperatively.
The RIFLE criteria were used to define the presence of acute kidney injury. In addition, the ratio between urinary
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and creatinine was measured.
Results: Ninety patients were included. Mean age was 76 ± 4 years and 76% were male. Mean arterial pressure was 47 ±
5mmHg in the control group and 61 ± 4mmHg in the high pressure group (p < 0.0001). The change in glomerular
filtration rate at follow-up was − 9 ± 12ml/min in the control group and − 5 ± 16ml/min in the high pressure group (p =
0.288, 95% CI − 13 to 4). According to the RIFLE criteria 38% in the control group and 46% in the high pressure group
developed acute kidney injury (p = 0.447). The postoperative urinary NGAL/creatinine ratio was comparable between the
groups.
Conclusions: An intended increase in arterial pressure during cardiopulmonary bypass to > 60mmHg did not decrease
the incidence of acute or chronic kidney injury after cardiac surgery.
Trial registration: Clinicaltrials.gov, identifier: NCT01408420. Registered 3rd of August 2011.
Keywords: Acute kidney injury, Arterial pressure, Cardiac surgery
Background
Acute kidney injury (AKI) is a well-known complication
to cardiac surgery and is associated with increased mortal-
ity [1–6]. The reported incidences range from 1 to 56% in
the literature [7–9].
The etiology behind the development of AKI after cardiac
surgery is incompletely understood and probably multifac-
torial. Possible contributing factors include systemic inflam-
matory response, microemboli and haemodilution. Some
studies have also indicated that the use of a heart-lung
machine versus off-pump beating heart surgery increases
the risk of AKI [10–12].
Furthermore, the management of flow and arterial pres-
sure (AP) during cardiopulmonary bypass (CPB) is not
evidence based [13]. It has been shown in a previous study
that a prolonged duration with an AP < 60mmHg during
CPB increases the risk of AKI [14]. The range of renal
autoregulation has been found to be between 75mmHg
and 160mmHg in an experimental setting [15]. During
CPB the AP is below this range the majority of the time.
Furthermore, the pressure during CPB is continuous and
not pulsatile as under normal conditions and the pressure
spikes of the systolic blood pressure are not present.
Therefore, when outside of the autoregulatory range of
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the kidneys, a higher-than-spontaneous AP during CPB
may improve renal microcirculation and decrease the risk
of AKI. In addition, it is unknown whether there is a cor-
relation between AKI and chronic kidney injury after car-
diac surgery.
The hypothesis of this study is that an intended high AP
during CPB decreases the incidence of acute and chronic
kidney injury in a population highly predisposed to AKI.
Methods
Ninety patients were enrolled in the study between May
2011 and December 2013 (clinicaltrials.gov identifier:
NCT01408420). All patients were operated at Rigshospi-
talet, Copenhagen University Hospital, Copenhagen,
Denmark. The study was approved by The Regional
Committee on Biomedical Research Ethics. Written in-
formed consent was received from all patients prior to
their inclusion in the study.
In- and exclusion criteria
To ensure that the cohort had a high preoperative risk of
developing AKI, the inclusion criteria were age > 70 years
and complex cardiac surgery procedures (heart valve and
bypass surgery in combination). Exclusion criteria were
serum creatinine (sCr) > 200 μmol/L, previous heart sur-
gery, endocarditis and acute operation defined as coronary
angiography < 24 h of surgery.
Randomisation
A parallel-group study was conducted where patients were
randomised into either a control group (CG) or a high
pressure group (HPG) using closed opaque envelopes that
were sequentially numbered. The allocation ratio was 1:1.
Randomisation was performed the day before surgery after
informed consent. The patients and outcome assessors
who analysed GFR, blood- and urine samples were
blinded until follow-up. The generation of the random al-
location sequence, the randomisation and enrolment of
patients were done by the first author of this paper.
Anaesthesia
Patients were premedicated with triazolam 0.125–0.250
mg orally 1 hour prior to surgery. Anaesthesia was in-
duced with fentanyl (10 μg/kg), propofol (1–2 mg/kg)
and cisatracurium (0.1 mg/kg). Maintenance of anaesthe-
sia was achieved using sevoflurane (0.5–3%) and con-
tinuous infusion of remifentanil (15 to 30 μg/kg/hour).
Intravenous administration of 1500 mg of cefuroxime
and a single-shot of 240 mg of gentamicin were given
after induction of anaesthesia. No specific guidelines
were used in regards to the administration of the single-
shot gentamicin. AP was recorded through a cannula
placed in the radial artery.
After heparinisation (350 IU/kg, ACT > 480 s), normo-
thermic CPB (36.5–37.0 °C bladder temperature) was initi-
ated as follows: in the ascending aorta an angled arterial
cannula was placed (DLP 24 FR, Medtronic, Minneapolis,
Minnesota) and a two-stage venous cannula (36/46 FR,
Medtronic) was inserted through the right atrial append-
age. A membrane oxygenator (Capiox RX25, Terumo,
Tokyo, Japan) and a roller pump (Stockert S5, Sorin
Group, Milano, Italy) were used for perfusion with non-
pulsatile flow. The arterial line included a 40-μm filter
(AL06, Pall, Port Washington, New York). Pump flow was
calculated by multiplying 2.4 L/minute by the body surface
area in square metres.
Intraoperative CPB data were retrieved from electronic
perfusion charts. The AP during CPB was sampled elec-
tronically every minute by the heart-lung machine. The
average AP during CPB was calculated using the values
from clamping to de-clamping of the ascending aorta.
Endpoints
The primary end-point of this study was mean change in
glomerular filtration rate (GFR) at follow-up compared
to baseline.
The secondary end-point were change in urinary Neu-
trophil Gelatinase-Associated Lipocalin (uNGAL) and
urinary creatinine ratios at different postoperative time-
points compared to baseline, a method that has been
shown to be highly sensitive in predicting AKI [16].
It was not possible to calculate sample size since no data
on 51Cr-ethylenendiaminetetra acetic acid plasma clear-
ance technique (Cr-EDTA) GFR measurements existed on
cardiac surgery patients at the initiation of the study.
Baseline u-NGAL and urine creatinine were measured
using urine samples taken just after induction of anaesthe-
sia and insertion of a urinary catheter. Postoperatively the
samples were taken at arrival to the intensive care unit
(ICU) and 6-, 18-, 48- and 120 h postoperative. The sam-
ples were centrifuged for 5min at 1000 RPM and the
supernatant was pipetted into cryotubes. The cryotubes
were placed in a freezer at − 80 degrees Celsius for a max-
imum of 9months before analysis, a period that has previ-
ously been found to be safe for storing uNGAL [17]. The
urine samples were analysed for uNGAL using the NGAL
Test reagent kit (BioPorto Diagnostics, Gentofte, Denmark)
on a Cobas c501 analyser (Roche, Basel, Switzerland) using
fully automated particle-enhanced turbidimetric immuno-
assay. On the same analyser urine creatinine levels were
measured to adjust for postoperative hydration status using
the Creatinine Plus version 2 reagent kit (CREP 2, Roche,
Basel, Switzerland).
GFR was measured by the 51Cr-ethylenendiaminetetra
acetic acid (EDTA) plasma clearance technique the day
before surgery and 4 months postoperative [18]. Four
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plasma samples were collected during 60 min within the
period of three to 5 hours after tracer injection.
Baseline sCr values were defined as the preoperative
value closest to the day of surgery. Postoperative sCr sam-
ples were taken in the morning of the first and second
postoperative day. The patients were characterised as ei-
ther AKI or no-AKI based on the RIFLE criteria. AKI was
present when an increase in sCr values of > 50% or abso-
lute increase of > 27 μmol/l occurred within the first 48 h
postoperative, compared to baseline. An estimated GFR
(eGFR) was calculated based on sCr using the Cockroft-
Gault formula. In accordance with the RIFLE criteria an
eGFR decrease of > 25% was also used to define AKI.
Intervention
In the CG the patients underwent standard anaesthesia
and CPB with the exception of a maximum of 110% flow
on the heart-lung machine.
In the HPG an infusion containing isotonic sodium
chloride and norepinephrine was mixed according to pa-
tient weight so that 1ml/hour equalled 0.01 μg/kg/min of
norepinephrine. This mixture was used when the AP was
< 60mmHg during CPB. If the target pressure could not be
reached the infusion rate was not increased above 30ml/
min. Maximum flow on the heart-lung machine was 110%.
Statistics
The study was conducted on an intention-to-treat basis.
Continuous data are presented as means ± standard
deviations (SD) or median (interquartile range). Con-
tinuous variables were compared by Student’s unpaired
t-test; categorical variables were compared by Pearson’s
chi-squared test. Mann-Whitney U-test was used to
compare sCr levels between the groups and u-NGAL/
creatinine ratios between the groups at each time-point
after correcting for the preoperative measurement.
Paired samples t-test was used to compare preoperative
GFR, eGFR and sCr with values at follow-up.
Differences were considered to be statistically signifi-
cant when the p value was < 0.05.
Statistical analysis was performed using the statistical soft-
ware package SPSS, version 22.0.0.0; SPSS Inc.; Chicago IL.
Results
Ninety patients were included from May 2011 to Octo-
ber 2013. Last patient follow-up was done January 2014.
Mean age was 76 ± 4 years and 76% were male.
No differences in preoperative data were found be-
tween the groups (Table 1). Intraoperative data were
comparable between the groups except the AP, which
was 47 ± 5mmHg and 61 ± 4mmHg in the CG and
HPG, respectively (p < 0.001) (Table 2). Postoperative
data, including short- and medium term survival,
incidence of acute kidney injury and GFR were equal be-
tween the groups (Table 3).
Forty-eight patients completed follow-up (25 patients in
the CG and 23 in the HPG). Six (7%) patients died in-
hospital (three patients in each group). Nine patients
(10%) died after discharge but before follow-up (4 patients
in the CG group and 5 patients in the HGP group). Four
(4%) patients declined to continue in the trial in the im-
mediate postoperative period (two in each group). The ac-
tual follow-up rate was therefore 48 out of 71 patients
(68%). Time of follow-up was 4.1 ± 1.5 months.
The secondary outcomes were analysed in all 90 pa-
tients. A participant flow diagram is presented in Fig. 1.
Glomerular filtration rate
For the total patient group a significant decline in GFR
following cardiac surgery was observed.
Preoperative and postoperative GFR was 78 ± 27ml/
min and 70 ± 26ml/min, respectively (p = 0.001). The
GFR change from baseline to follow-up did not differ
between the two groups, − 9 ± 12 ml/min in the CG and
− 5 ± 16 ml/min in the HPG (p = 0.288) (Table 3).
Eleven patients (44%) in the CG and 9 (39%) in the
HPG had a GFR drop of > 10% at follow-up compared
to baseline (p = 0.732). At follow-up 9 patients (36%) in
the CG group and 5 (22%) in the HPG had a GFR drop
of > 20% (p = 0.278).
Table 1 Preoperative data
CG HPG p value 95% CI
N 45 45 –
Male gender 33 (73%) 32 (71%) 0.450
Age (years) 76.3 ± 4.2 76.6 ± 4.7 0.731 −2 to 2
BSA (m2) 1.93 ± 0.19 1.91 ± 0.18 0.611 − 0.07 to 0.10
BMI (kg/m2) 26.5 ± 3.70 27.2 ± 4.70 0.519 −2.5 to 1.1
EuroSCORE II 3 (2–5) 3 (3–5) 0.264 −1 to 1
Hypertension 31 (80%) 26 (68%) 0.268
COPD 2 (5%) 0 (0%) 0.157
NIDDM 3 (8%) 8 (21%) 0.094
IDDM 2 (5%) 3 (8%) 0.622
PAD 7 (18%) 3 (8%) 0.189
CD 6 (15%) 5 (13%) 0.780
GFR (ml/min) 77 ± 21 69 ± 28 0.142 −3 to 19
sCr (μmol/dl) 88 (80–101) 84 (69–116) 0.452 −18 to 12
eGFR (ml/min) 72 ± 22 71 ± 29 0.966 − 11 to 11
Percentages are given as total within group. Continuous data are presented as
mean ± SD or median (interquartile min – max)
BSA Body surface area, BMI Body mass index, CI confidence interval, COPD
Chronic Obstructive Pulmonary Disease, IDDM Insulin-Dependent Diabetes
Mellitus, NIDDM Non-Insulin-Dependent Diabetes Mellitus, PAD Peripheral
Arterial Disease, CD Cerebral disease, eGFR Estimated glomerular filtration rate
(calculated using the Cockroft-Gault formula), GFR Glomerular filtration rate
(estimated by Cr-EDTA clearance), sCr Serum creatinine
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Acute kidney injury
The uNGAL/creatinine ratio was not significant between
the two groups at any time-point (Table 4).
35 (41%) of the patients developed AKI according to
the RIFLE criteria. No significant differences were found
in the incidence of AKI between the groups which was
16 (38%) and 19 (46%) in the CG and HPG respectively
(p = 0.447). 7 patients received renal replacement ther-
apy during the hospital stay of which 4 (9%) were in the
CG and 3 (7%) in the HPG (p = 0.565)
Among AKI patients, 12 out of 17 (71%) had a de-
crease in GFR > 10% at follow-up. In patients who did
not develop AKI 8 out of 31 (26%) patients had a GFR
decrease > 10%. The difference in proportion of patients
with a GFR decrease > 10% were statistically significant
between AKI and no-AKI patients (p = 0.003).
The results of a sub-analysis comparing patients who
develop AKI with patients who do not develop AKI
looking at specific risk factors are presented in Table 5.
No significant risk factors of AKI were identified.
Cause of death after discharge but before follow-up
was cardiac related death in three patients and one pa-
tient in the CG and HPG, respectively. One patient in
each group died from infection. One patient in the CG
died from intracerebral haemorrhage. Dehydration and
cancer was the cause of death in two patients in the
HPG. No patients that died before follow-up were in the
need of dialysis. No significant difference in the cause of
Table 2 Intraoperative data
CG HPG p value 95% CI
AP (mmHg) 47 ± 5 61 ± 4 < 0.001 −15 to − 11
Flow (L/min/m2) 2.6 ± 0.2 2.6 ± 0.2 0.810 − 0.1 to 0.1
CABG + AVR 38 (84%) 36 (80%) 0.415
CABG +MVR 4 (9%) 8 (18%) 0.290
AVR +MVR 1 (2%) 0 (0%) 0.314
CPB time (min) 130 ± 36 130 ± 31 0.994 −30 to 19
XC time (min) 100 ± 39 93 ± 22 0.310 −19 to 12
Blood loss (ml) 636 ± 482 667 ± 397 0.759 − 222 to 153
Diuresis (ml) 517 ± 294 639 ± 438 0.152 − 299 to 15
Change in HCT (%) −8 ± 5 −7 ± 4 0.069 −4 to 0
Fluid balance (ml) 1490 ± 1206 1246 ± 968 0.327 − 382 to 753
Gentamicin administered 31 (78%) 32 (80%) 0.353
Percentages are given as total within group. Continuous data are presented as mean ± SD
AP Arterial pressure, AVR Aortiv valve replacement, CI confidence interval, CPB Cardiopulmonary bypass, HCT Haematocrit, MVR Mitral valve replacement, XC Aortic
cross clamp
Table 3 Postoperative data
CG HPG p value 95% CI
Delta sCr (mmol/L) 20 (6–51) 25 (10–49) 0.560 −18 to 18
Delta eGFR (ml/min) −6 (− 15–4) − 3 (− 13–5) 0.522 −7 to 5
AKI 16 (38%) 19 (46%) 0.447
Dialysis 4 (10%) 3 (7%) 0.565
Re-operation 4 (10%) 1 (3%) 0.165
Stroke 3 (8%) 2 (5%) 0.687
4 months follow-up
Change in GFR (ml/min) − 9 ± 12 −5 ± 16 0.288 −13 to 4
> 10% decrease in GFRa 11 (44%) 9 (39%) 0.732
30-day mortality 3 (7%) 3 (7%) 1.000
6-months mortality 7 (16%) 8 (18%) 0.763
Percentages are given as total within group. Continuous data are presented as mean ± SD or median (interquartile min – max)
AKI Acute kidney injury, CI confidence interval, AP Arterial pressure, eGFR Estimated glomerular filtration rate (calculated using the Cockroft-Gault formula), GFR
Glomerular filtration rate (estimated by Cr-EDTA clearance), sCr Serum creatinine
aPercentages of total of patients at follow-up
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death was found between the groups. Data on mortality
are shown in Table 3.
Discussion
We present a study conducted on cardiac surgery pa-
tients who had a high risk of developing AKI by using
age > 70 years and complex cardiac procedures as inclu-
sion criteria. To our knowledge this is the first rando-
mised study on the subject that have long-term renal
outcome as the primary outcome, not only by looking at
sCr or eGFR, but using measured GFR by using the Cr-
EDTA clearance method.
Fig. 1 Participant flow diagram
Table 4 uNGAL/creatinine changes from baseline (ng/mL)
CG HPG p value
Preoperative (baseline) 2 (1–4) 2 (1–5) 0.824
Postoperative 42 (11–141) 40 (19–141) 0.720
6 h 8 (4–58) 10 (2–40) 0.768
18 h 1 (0–6) 2 (0–8) 0.744
48 h 3 (0–6) 4 (1–6) 0.596
120 h 2 (0–5) 4 (1–10) 0.301
Data is presented as median (interquartile min – max)
Table 5 Subanalysis of potential risk factors of AKI
No-AKI AKI p value
N 51 36
Male gender 35 (69%) 29 (80%) 0.176
Age 76 ± 4 77 ± 5 0.098
BMI (kg/m2) 26 ± 4 28 ± 5 0.061
EuroSCORE II 3 (2–5) 3 (2–4) 0.865
GFR 73 ± 28 74 ± 21 0.867
sCr 87 (75–104) 85 (75–109) 0.836
eGFR 67 ± 28 75 ± 24 0.171
AP 54 ± 8 54 ± 8 0.802
CPB time 124 ± 29 138 ± 37 0.073
Gentamicin administered 38 (83%) 24 (73%) 0.155
Percentages are given as total within AKI-group. Continuous data are
presented as mean ± SD or median (interquartile min – max)
AKI Acute kidney injury, AP Arterial pressure, BMI Body mass index, CPB
Cardiopulmonary bypass, GFR Glomerular filtration rate, HCT Haematocrit, XC
Aortic cross clamp
Kandler et al. Journal of Cardiothoracic Surgery          (2019) 14:107 Page 5 of 7
Long-term renal function
A significant loss of GFR in both groups was observed at
follow-up. Cardiac surgery should therefore be consid-
ered not only a risk factor for developing AKI but also a
risk factor of permanent loss of renal function.
The primary finding of this study was that an intended
increase in AP to > 60mmHg during CPB using nor-
epinephrine did not result in any significant differences
in GFR change from preoperative values to follow-up
compared to lower intraoperative arterial pressures. This
suggests that AP during CPB does not influence long-
term renal function. However, overall measured GFR
had decreased nearly 10% on average 4months after sur-
gery. Additionally, the development of AKI < 48 h post-
operative was associated with a GFR reduction of > 10%
at follow-up. Cardiac surgery should therefore be con-
sidered not only a risk factor for developing AKI but
seems to result in a permanent loss of renal function in
elderly patients undergoing complex cardiac surgery.
This permanent loss of renal function has not been pre-
viously described and should be taken into consideration
when planning surgery in this group of patients.
Short-term renal function
The secondary objective of this study was to investigate the
relationship between AP during CPB and short-term renal
function, defined by uNGAL/creatinine ratio and AKI.
By using inclusion criteria defining individuals in high
risk of AKI, the study population had an AKI incidence of
41% in total. The reported incidence of AKI in the literature
is 1–56% [7–9].
The incidence of AKI, estimated by the RIFLE criteria,
was found to be equal in the two groups. The ratio of
uNGAL/creatinine was also equal between the groups at all
time-points. The uNGAL/creatinine ratio was significantly
increased immediately postoperative and 6 h postoperative,
indicating damage to the renal parenchyma due to intraop-
erative factors.
Only a few randomised studies exist investigating arterial
pressure during CPB in relation to kidney injury as a pri-
mary outcome. One study used no age restrictions and in-
cluded both combined and non-combined valve and
CABG surgery [19]. Patients were randomised into three
AP groups, ranging from an AP < 60mmHg to > 70
mmHg. The primary endpoint was AKI defined by the RI-
FLE criteria. Eleven percent of the patients developed AKI.
No differences regarding the incidence of AKI were found
between the three groups. Another study used age > 70
years as inclusion criterion as in our study, but only in-
cluded CABG patients [20]. Patients were randomised into
the same AP groups as in the above mentioned study. The
incidence of AKI was equal between the groups. Both stud-
ies used the same lower AP threshold as in our study, i.e.
< 60mmHg.
A large randomized study conducted on 300 patients
aimed for an even higher AP of 75–85mmHg in the
control group [21]. The target AP in the control group
was 50–60mmHg which is similar to the present study
and the above mentioned studies. The outcome was AKI
defined by changes in sCr. The rate of AKI in the groups
was 17% vs. 17% (p = 1). The mean AP reached in the
control group was 60 ± 6mmHg, which is close to the
AP in the control group of our study. This supports our
findings and suggests that even very high AP during
CPB does not protect the kidneys. At least not in terms
of acute kidney injury.
A recent study with a more direct approach of meas-
uring renal function by renal vein catheterization sug-
gests that a higher flow than 2.4 L/min/m2 is beneficial
for the kidneys [22]. The increased flow rates used were
2.7 L/min/m2 and 3.0 L/min/m2 which improved the
renal oxygen supply/demand relationship by 14 and 30%
respectively.
The above mentioned studies, in addition to our study,
indicate that AP during CPB has no influence on the in-
cidence of AKI on a broad range of patients and proce-
dures. In addition, future randomised studies should also
investigate the relationship between arterial flow and
renal function.
Limitations
This study used an AP of > 60mmHg as the aim in the
HPG. Therefore, it still remains unclear if even higher
APs could decrease the risk of kidney injury.
The RIFLE criteria used to define AKI is based on sCr,
which varies depending on age, gender, muscle mass and
race. This is partly adjusted for since the patient’s own
sCr is used as baseline and adjusted for age, gender and
weight to calculate eGFR. However, in the postoperative
period sCr can also vary considerably depending on the
degree of haemodilution, making the values less reliable.
The number of patients lost to follow-up was high and
the cohort size was relatively small. Although the num-
bers were the same in both groups there is still a risk of
loss to follow-up bias.
It was not possible to perform a sample size calcula-
tion prior to the study since no previous data was avail-
able on GFR measurements on the patient category that
was included in the study.
Conclusion
An intended AP > 60mmHg during CPB did not seem
to decrease the risk of acute or chronic kidney injury in
patients > 70 years of age undergoing concomitant car-
diac surgical procedures. Cardiac surgery generally re-
sulted in a substantial loss of renal function measured at
follow-up 4months postoperatively.
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